How big is Delix Therapeutics Inc.'s plan?

Delix Therapeutics Inc.'s plan reported $3.1M in assets and 9 participants for 2025.

Original filing (PDF)20260423220450NAL0005237409055

Delix Therapeutics Inc.

Name: Delix Therapeutics Inc. — Delix Therapeutics Inc., Form 5500 (2025)
Creator: Delix Therapeutics Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Delix Therapeutics Inc. 401(k) Plan

401(k) retirement plan · Delix Therapeutics Inc.'s Delix Therapeutics Inc. 401(k) Plan held $3.1M in plan assets for 9 participants in 2025.

Active participants

Accounts w/ balance

Plan assets (EOY)

$3.1M

Net assets (EOY)

$3.1M

People on this filing

Elantha Barry signed Delix Therapeutics Inc.'s 2025 Form 5500 as plan administrator.

Elantha Barry — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Delix Therapeutics Inc.'s EIN is 84-2512594.

EIN 84-2512594

Plan number 001

Plan year 2025

ACK ID 20260423220450NAL0005237409055

Official Form 5500 document

Download the official 2025 Form 5500 (PDF) for Delix Therapeutics Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2025 Form 5500 (PDF)

Plan features

Delix Therapeutics Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, automatic enrollment, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for DELIX THERAPEUTICS INC.

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

Vendor & structure

100

Helping the score

Cost not scored — no comparable Schedule H expense data for this cohort.
High account-holder ratio — balance-holders per active participant in the top 15% of peers (97th percentile).

Plan sponsor

Name

DELIX THERAPEUTICS INC

EIN

all filings

Address

20 AUTHORS ROAD · CONCORD, MA · 01742

Phone

(617) 775-9325

Industry

Manufacturing

Plan administrator